Cargando…
Sulodexide in the treatment of patients with long COVID 19 symptoms and endothelial dysfunction: The results of TUN-EndCOV study
BACKGROUND: Endothelial dysfunction is probably one of the mechanisms of long COVID-19 symptoms. Sulodexide has pleiotropic properties within the vascular endothelium that can prove beneficial in the long COVID-19 symptoms. PURPOSE: We aimed to evaluate the effect of sulodexide when used in patients...
Autores principales: | Charfeddine, S., Ibn Hadjamor, H., Torjmen, S., Kraiem, S., Hammami, R., Bahloul, A., Kallel, N., Moussa, N., Touil, I., Jdidi, J., Abdesselem, S., Abid, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710949/ http://dx.doi.org/10.1016/j.acvdsp.2021.10.007 |
Ejemplares similares
-
Endothelial dysfunction is the key of long COVID-19 symptoms: The results of TUN-EndCOV study
por: Charfeddine, S., et al.
Publicado: (2022) -
Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study
por: Charfeddine, Salma, et al.
Publicado: (2022) -
Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study
por: Charfeddine, Salma, et al.
Publicado: (2021) -
Poor Outcomes of COVID-19 in Lung Transplant Recipients. Cohort Study in a Single Center
por: Amor, S.M., et al.
Publicado: (2021) -
Les patients diabétiques en post-COVID-19
por: Bani, I., et al.
Publicado: (2023)